Trump Signs Executive Order for Expanded Research on Psychedelic Drugs Like Ibogaine
President Donald Trump has signed an executive order urging more research into psychedelic drugs like ibogaine, as part of a broader push to explore emerging mental health treatments. The move aims to expand research into these substances and their potential therapeutic applications.
President Donald Trump has signed an executive order calling for more research into psychedelic drugs like ibogaine, as part of a broader effort to investigate emerging mental health treatments. The move is seen as a step towards harnessing the potential therapeutic benefits of these substances. Research into psychedelics has gained significant attention in recent years due to promising results in treating conditions such as depression and addiction. The executive order aims to accelerate this research and unlock new possibilities for mental health treatment.
